Pinned post
Thank you, @POTUS for sharing our work!!
View quoted post on X
Paragon Health Institute
Verified account This account is verified because it's an official organization on X. Learn more@Paragon_Inst
Reforming government. Empowering patients. Pragmatic and market driven health policy solutions Americans can trust.
547 Following 2.4K Followers 3.4K Posts
Latest posts 5
CMS just finalized the 2027 OPPS and PFS rules.
@HammondOnHealth breaks down how OPPS expands site-neutral payment and aligns 340B drug payments with acquisition costs, while PFS advances site-neutral policies for imaging without contrast and moves physician practice expense payments toward a more objective, transparent methodology.
Read it ⬇️
paragoninstitute.org/paragon-progno…
@HammondOnHealth breaks down how OPPS expands site-neutral payment and aligns 340B drug payments with acquisition costs, while PFS advances site-neutral policies for imaging without contrast and moves physician practice expense payments toward a more objective, transparent methodology.
Read it ⬇️
paragoninstitute.org/paragon-progno…
paragoninstitute.org CMS Finalizes 2027 Outpatient and Physician Payment Rules The OPPS rule aligns Medicare payment for 340B drugs with hospitals’ acquisition costs, expands site-neutral payment. CMS finalized its 2027 outpatient payment rule, moving Medicare closer to paying the same amount for the same service.
The rule reforms 340B drug payments, expands site-neutral payment, and broadens access to ambulatory surgery.
paragoninstitute.org/paragon-progno…
The rule reforms 340B drug payments, expands site-neutral payment, and broadens access to ambulatory surgery.
paragoninstitute.org/paragon-progno…
In 2024, an estimated 14.3 million people were improperly enrolled in the ACA exchanges or Medicaid expansion, at a federal cost of about $65 billion:
ow.ly/XhUu5103L17
ow.ly/XhUu5103L17
340B drug purchases grew from $12 billion in 2015 to $100 billion in 2025.
A new HHS ASPE report finds the program's margins reward consolidation and higher-priced drugs. @brian_blase on the report and what CMS has proposed:
ow.ly/e3IP5103L4Q
A new HHS ASPE report finds the program's margins reward consolidation and higher-priced drugs. @brian_blase on the report and what CMS has proposed:
ow.ly/e3IP5103L4Q
paragoninstitute.org Modernizing the FDA and Addressing 340B’s Costly Incentives Early-stage clinical research is shifting away from the United States. China registered more than 7,100 clinical trials in 2024.